J&J app aggregates info for doctors

Johnson & Johnson used its JNJ BTW blog to introduce an iPhone app for docs, titled BlackBag. The app was developed internally, and features customizable—by therapeutic area—news feeds, journal summaries, conference coverage, videos and podcasts.

Content delivered through the app—billed as a proverbial medical “black bag” of tools—includes news feeds from Reuters, Medical News Today, Health Day and others, according to Lars Merk, product director at Ortho-McNeil-Janssen Pharmaceuticals.

According to Merk, J&J developers are “watching user response to determine what might be next,” noting that J&J reached out to Sermo docs for insight into what kinds of tools should be added to BlackBag. Merk said branded messages will appear at “natural points in the app where physicians want branded information such as dosing, safety and patient information...if it is something that healthcare professionals desire we will look to create ways to deliver that information in the app, or through related technologies available on the iPhone.” There isn't currently a CME function on the app.

Merk said that other, similar iPhone apps are available, but noted that iPhone users seldom download just one application.

“Certainly [applications like WebMD's] Medscape offer healthcare professionals some very valuable content. The BlackBag app is being designed to take advantage of all the best digital content that is available to healthcare professionals,”  said Merk.

Within the first two months of launching, BlackBag was downloaded by approximately 24,000 users, according to the JNJ BTW post. WebMD launched its Medscape app in July—after BlackBag, notes Merk—offering physicians “specialty-specific news,” drug information, clinical reference tools and CME.

You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.